Keyphrases
Indonesia
100%
Surabaya
55%
Tuberculosis Patients
25%
Mycobacterium Tuberculosis (M. tb)
25%
Tuberculosis
24%
COVID-19
21%
Indonesian
17%
Pulmonary Tuberculosis
17%
Hepatitis B Virus
16%
Hepatitis C Virus
15%
Multidrug-resistant Tuberculosis (MDR-TB)
11%
Risk Factors
9%
Escherichia Coli
8%
East Java Indonesia
7%
Methicillin-resistant Staphylococcus Aureus
7%
Pseudomonas Aeruginosa (P. aeruginosa)
7%
Indonesian Patients
7%
Gram-negative Bacteria
7%
Genotype
7%
Klebsiella Pneumoniae (K. pneumoniae)
7%
Tertiary Referral Hospital
7%
Clinical Outcomes
6%
In Vitro Study
6%
AIDS/HIV
6%
Academic Hospital
6%
Biofilm
6%
Sputum
6%
Acinetobacter Baumannii (A. baumannii)
6%
Staphylococcus Aureus
6%
Tuberculosis Diagnosis
6%
Peripheral Blood Mononuclear Cells
6%
Candida Albicans (C. albicans)
6%
Rifampicin
5%
Quantitative PCR
5%
Referral Hospital
5%
HIV Patients
5%
Interleukin-6
5%
Urinary Tract Infection
5%
Neonatal Sepsis
5%
TB Patients
5%
Antibiotics
5%
Xpert MTB
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
27%
Prevalence
25%
Diseases
19%
Lung Tuberculosis
18%
Mycobacterium Tuberculosis
17%
SARS Coronavirus
13%
Hepatitis C Virus
13%
Pseudomonas aeruginosa
12%
HIV
12%
Carbapenem
11%
Rifampicin
10%
Hepatitis B Virus
10%
Infectious Agent
8%
Acinetobacter Baumannii
8%
Antibiotics
8%
Staphylococcus Aureus
7%
Drug Resistant Tuberculosis
7%
Coronavirinae
7%
Escherichia coli
7%
Candida Albicans
7%
Methicillin-Resistant Staphylococcus Aureus
6%
Candida
6%
Antimicrobial Resistance
6%
Bloodstream Infection
6%
Diabetes Mellitus
5%
Cytokine
5%
Hemodialysis
5%
Extended Spectrum Beta Lactamase
5%
Gram Negative Bacterium
5%
Antiinfective Agent
5%
Tuberculosis
5%
Mixed Infection
5%
Inflammation
5%
Medicine and Dentistry
Mycobacterium Tuberculosis
12%
Lung Tuberculosis
12%
Infection
11%
Prevalence
11%
Sputum
9%
COVID-19
9%
Diseases
8%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Acinetobacter Baumannii
5%
Neonatal Sepsis
5%
Human Immunodeficiency Virus
5%
Rifampicin
5%